HDAC inhibitors in acute myeloid leukemia

E San José-Enériz, N Gimenez-Camino, X Agirre… - Cancers, 2019 - mdpi.com
Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled
proliferation, differentiation arrest, and accumulation of immature myeloid progenitors …

Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer's disease

S Maity, K Farrell, S Navabpour, SN Narayanan… - International journal of …, 2021 - mdpi.com
Epigenetic mechanisms, which include DNA methylation, a variety of post-translational
modifications of histone proteins (acetylation, phosphorylation, methylation, ubiquitination …

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

J Tan, S Cang, Y Ma, RL Petrillo, D Liu - Journal of hematology & oncology, 2010 - Springer
Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and
activities of transcriptional factors involved in both cancer initiation and progression through …

[PDF][PDF] Liver stem cells and hepatocellular carcinoma

L Mishra, T Banker, J Murray, S Byers… - …, 2009 - Wiley Online Library
Although the existence of cancer stem cells (CSCs) was first proposed over 40 years ago,
only in the past decade have these cells been identified in hematological malignancies, and …

Combination of chidamide-mediated epigenetic modulation with immunotherapy: Boosting tumor immunogenicity and response to PD-1/PD-L1 blockade

K Tu, Y Yu, Y Wang, T Yang, Q Hu, X Qin… - … applied materials & …, 2021 - ACS Publications
Improving tumor immunogenicity is critical for increasing the responsiveness of triple-
negative breast cancer (TNBC) to anti-PD-(L) 1 treatment. Here, we verified that chidamide …

Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions

J Lee, J Lee, KS Farquhar, J Yun… - Proceedings of the …, 2014 - National Acad Sciences
The sources and consequences of nongenetic variability in metastatic progression are
largely unknown. To address these questions, we characterized a transcriptional regulatory …

Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy

N Adhikari, T Jha, B Ghosh - Journal of Medicinal Chemistry, 2021 - ACS Publications
The acetylation of histone and non-histone proteins has been implicated in several disease
states. Modulation of such epigenetic modifications has therefore made histone …

Revisiting histone deacetylases in human tumorigenesis: The paradigm of urothelial bladder cancer

AF Giannopoulou, AD Velentzas… - International journal of …, 2019 - mdpi.com
Urinary bladder cancer is a common malignancy, being characterized by substantial patient
mortality and management cost. Its high somatic-mutation frequency and molecular …

Upregulation of key molecules for targeted imaging and therapy

VF Taelman, P Radojewski, N Marincek… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Targeted diagnosis and therapy enable precise tumor detection and treatment. Successful
examples for precise tumor targeting are diagnostic and therapeutic radioligands. However …

Biological basis for novel mesothelioma therapies

J Obacz, H Yung, M Shamseddin, E Linnane… - British Journal of …, 2021 - nature.com
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …